Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
triamcinolone acetonide + bupivacaine hydrochloride + povidone-iodine + lidocaine
- Development stage
- Unknown
- Lead developer
- Rx Pharma-pack
- Modality
- Small Molecules
- Administration
- Injectable, Topical
01
Overview
A multi-ingredient pharmaceutical combination used in procedure kits for local or regional anesthesia and peri-procedural analgesia, typically pairing **triamcinolone acetonide** as an anti-inflammatory corticosteroid, **bupivacaine hydrochloride** and **lidocaine** as local anesthetics, and **povidone-iodine** as a topical antiseptic for skin preparation. Based on the provided source context, this exact ingredient combination appears in commercial procedure kits such as P-CARE K40MX and similar kits distributed by RX PHARMA-PACK. The therapeutic effect is driven by sodium-channel blockade from lidocaine and bupivacaine to produce local anesthesia/analgesia, together with glucocorticoid receptor agonism by triamcinolone acetonide to reduce inflammation; povidone-iodine contributes antisepsis rather than analgesic efficacy.
- Other names
- triamcinolone acetonide + bupivacaine hydrochloride + povidone-iodine + lidocaine
02
Targets
GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on triamcinolone acetonide + bupivacaine hydrochloride + povidone-iodine + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on triamcinolone acetonide + bupivacaine hydrochloride + povidone-iodine + lidocaine.